New Stroke Prophylaxis Options in Atrial Fibrillation Patients. Review uri icon

Overview

abstract

  • Atrial Fibrillation (AF) is an epidemic that is increasing in size and scope. AF can have many symptoms and cause a variety of negative health impacts.The most important health risk of AF is the increased risk of stroke and systemic thromboembolism.Oral anticoagulation with warfarin has been the gold standard for stroke risk reduction in AF, but new drugs and treatment strategies for AF are changing clinical practice. These new advances could offer better tailoring of treatments to patients with high risk of stroke while reducing the potential bleeding complications.

publication date

  • February 12, 2013

Identity

PubMed Central ID

  • PMC5153098

Digital Object Identifier (DOI)

  • 10.4022/jafib.462

PubMed ID

  • 28496803

Additional Document Info

volume

  • 5

issue

  • 5